be_ixf;ym_202603 d_01; ct_50
NYSE:AGL charts & data provided by TradingView

Latest Insights on AGL

This week, we shared some of the best Sovereign Investor Daily articles of 2019. It was a busy week because of the holidays, though … so you might have missed some of them. Week in Review: The Can’t-Miss Stock Insights from 2019 December 28, 2019 by Jay Goldberg Trending, Winning Investor Daily This week, we shared some of the best Sovereign Investor Daily articles of 2019. It was a busy week because of the holidays, though … so you might have missed some of them.
[UPDATE]: 2 Great Real Estate Stocks for the New Year December 26, 2019 by Brian Christopher Investment Opportunities, Real Estate, Winning Investor Daily I met with a group of well-connected folks in the world of commercial real estate. It was fitting to talk about investing in buildings while surrounded by some of the most beautiful real estate I’ve ever seen.…
How You Can Profit From Tariffs on Brazil and the Trade War December 4, 2019 by John Ross American Investor Today, Economy, Investing, Investment Opportunities, U.S. Economy John’s Chart of the Week predicts a 16% climb for an index of Brazil’s top stocks in three months’ time — despite President Trump’s threat to restore tariffs. John shares a way you can magnify those gains for a chance to get 10 times the return in a shorter period. (3-minute read)
Great Stuff 7-5-2019 Friday Four Play: Good Jobs = Bad News July 5, 2019 by Joseph Hargett Great Stuff That was quite the Fourth of July celebration, wasn’t it? The fireworks, the music … and stuff. Freedom was everywhere. It was awesome. I don’t know about you, but I’m beat this morning. Apparently, so is the market. But we’ll get to that in a minute. Next week, I’m going on vacation to celebrate my […]
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition June 25, 2019 by Joseph Hargett Great Stuff I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

Share This